Table 4.
Males | Predicted (mL) | % FVCms | % FVCpr | δ (%) | T v N (mL) | T v N (mL/Kg) |
---|---|---|---|---|---|---|
Athletes, n = 156 | ||||||
T v | 454.4 ± 3.97 | 7.9 ± 0.86* | 8.6 ± 0.03* | 0.7 ± 0.08 | 502.7 ± 6.9 | 6.6 ± 0.07 |
| ||||||
Nonathletes, n = 113 | ||||||
T v | 438.3 ± 3.4 | 9.5 ± 0.12* | 9.1 ± 0.06* | −0.3 ± 0.01 | 426.0 ± 5.5 | 5.8 ± 0.07 |
| ||||||
Females | Predicted (mL) | % FVCm | % FVCpr | δ (%) | T v N (mL) | T v N (mL/Kg) |
| ||||||
Athletes, n = 95 | ||||||
T v | 375.4 ± 4.6 | 8.7 ± 0.12* | 9.4 ± 0.05* | 0.6 ± 0.01 | 408.9 ± 7.1 | 6.5 ± 0.08 |
| ||||||
Nonathletes, n = 122 | ||||||
T v | 319.3 ± 3.6 | 9.9 ± 0.15* | 10.3 ± 0.09* | 0.3 ± 0.01 | 333.1 ± 4.9 | 6.3 ± 0.07 |
FVC: forced vital capacity, Ms: measured, and Pr: predicted. *P < 0.0001, **P < 0.001.